Aphria's Stock Is Up Double-Digits Since Shorts Tried to Attack

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Cannabis Profits Daily. If you have any questions or would like to change free your email settings, please reference the contact information at the bottom of this email.

Thursday, January 3, 2019 Aphria's Stock Is Up Double-Digits Since Shorts Tried to Attack By Greg Miller A few weeks ago, a short-seller published a highly critical report about Aphria Inc. (NYSE: APHA). Although many of the allegations have yet to be proven, the effect was devastating with the stock falling by 40% in just two days. It was not the first short-seller report about a cannabis stock - and it will not be the last. In Aphria's case, the National Institute for Cannabis Investors believed the attack created an unusual and outstanding buying opportunity. In fact, we said on December 6 that investors like yourself should seriously consider adding some Aphria to your portfolios. From that point up to yesterday's close of trading, Aphria is up 14.9%. Whenever a hot sector comes under some near-term pressure, the shorts - investors who essentially bet a stock will go down - come out to play. The more aggressive shorts will publicize their reasons for thinking a stock is overvalued. This often drives the stock down, to the profit of that short. Because they have a profit motive in bringing a stock down, it's important to scrutinize their reports. But it's also important to pay some attention to what the shorts are saying because sometimes they uncover uncomfortable truths about a company that supporters have missed and the company's management would prefer to stay secret. I want to take some time to talk about shorts generally: what they are, what they do, why it's important to be skeptical, and why it's also important to have an open mind to their findings. Let's take a look... Four Cannabis Stocks to Watch in 2019 Little-Known Secret: Why IPOs Can Make Early Investors Millions Uncover the IPO Strategy That One Man Used to Create $2.2 Billion in Less Than Two Years How to Become an Angel Investor in Tomorrow's Biggest Cannabis Company For years, Angel Investing was reserved for the America's most elite investors - only the wealthiest 2% could secure a deal. But not anymore. Thanks to a recent federal law change, you don't have to be a multi-millionaire to break into the startup market. In fact, average investors now have the chance to make a run at these opportunities before the bigger players move in. And let me tell you, the profit potential at stake is too good to ignore. Better yet, the next company to deliver a potential windfall... we believe it'll be a cannabis company. In fact, our analysts believe it'll be the cannabis company we recently shared with our readers. And if you click here now, we'll show you how you can become an angel investor in America's next great industry. Danny is famous for being the "behind-the-scenes" architect for two of the biggest IPOs in cannabis history. The two cannabis firms he's helped take public have created $2.2 billion in new wealth for shareholders. Fact is, he has the power to open doors in the cannabis industry that only a few can. That's why we wanted to sit down with Danny and extract his wisdom regarding the current market climate for cannabis IPOs. We got him to talk about where the "big money" can be made, the ripple effects of full U.S. legalization and more... He's even going to reveal four cannabis IPO recommendations he's got locked and loaded for you right now. All you have to do is click the link below to get all of Danny's insights, including where he believes investors should put their money right now. You are receiving this e-mail at its028@gmail.com, as a part of your subscription. Remove your email from this list: Unsubscribe © 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 Contact Customer Service Website: https://nicinvestors.com Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201. Privacy Policy | Terms & Conditions